FDA Drug Application (203684) for LUMASON by BRACCO

Back to FDA Applications sponsored by BRACCO

Application Number203684
Product Number001
FormFOR SUSPENSION;INTRAVENOUS
Dosage60.7MG/25MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameLUMASON
Active IngredientSULFUR HEXAFLUORIDE LIPID-TYPE A MICROSPHERES



Back to FDA Applications sponsored by BRACCO